EUVIMEDOpdag EUVIMED
Fallbericht

Oral Lichen Planus Successfully Treated With Upadacitinib

Kristin Slater, Katelyn Halash, Francisca Kartono

Journal of Drugs in Dermatology · 2024

DOI: 10.36849/jdd.7859 ↗

At a glance

Fallbericht in Journal of Drugs in Dermatology, 2024. Written by Kristin Slater and 2 co-authors. Major MEDLINE topics: Lichen Planus, Oral, Janus Kinase Inhibitors. Cited 14 times so far (Crossref).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

With the rise of Janus kinase (JAK) and Signal Transducer and Activator of Transcription (STAT) inhibitor use in dermatologic conditions, there has been increasing hope in treating extensive and difficult-to-treat inflammatory cutaneous conditions. Today we report a case of oral lichen planus successfully treated with an oral JAK1 inhibitor, upadacitinib. This case had been unresponsive by several standard methods but responded with 70% improvement within 1 month when treated with upadacitinib. J Drugs Dermatol. 2024;23(4):7859. doi:10.36849/JDD.7859e .

Subjects

MeSH terms (MEDLINE)

Lichen Planus, OralJanus Kinase InhibitorsHumansJanus KinasesHeterocyclic Compounds, 3-Ring

Substances

upadacitinibJanus KinasesJanus Kinase InhibitorsHeterocyclic Compounds, 3-Ring

Cite

APA

Slater, K., Halash, K., & Kartono, F. (2024). Oral Lichen Planus Successfully Treated With Upadacitinib. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7859

Vancouver

Slater K, Halash K, Kartono F. Oral Lichen Planus Successfully Treated With Upadacitinib. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.7859

BibTeX
@article{Slater2024,
  author = {Slater, Kristin and Halash, Katelyn and Kartono, Francisca},
  title = {Oral Lichen Planus Successfully Treated With Upadacitinib},
  journal = {Journal of Drugs in Dermatology},
  year = {2024},
  doi = {10.36849/jdd.7859}
}
Start for free →